Paper39339151
Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication.
Zheng X and 9 others. Pharmaceutics, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication. Papers, record 39339151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39339151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 32100122 | National Natural Science Foundation of China | PubMed | ||
| 21YF1457800 | Shanghai Sailing Program | PubMed |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22427407 | Impaired quality of life after chikungunya virus infection: a 2-year follow-up study. | Rheumatology (Oxford) | 2012 | https://conductscience.org/library/papers/22427407 | PubMed |
| 2 | 24721536 | Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. | Euro Surveill | 2014 | https://conductscience.org/library/papers/24721536 | PubMed |
| 3 | 31574966 | Importance of Zika Virus NS5 Protein for Viral Replication. | Pathogens | 2019 | https://conductscience.org/library/papers/31574966 | PubMed |
| 4 | 35644833 | Identification of clinical candidates against West Nile virus by activity screening in vitro and effect evaluation in vivo. | J Med Virol | 2022 | https://conductscience.org/library/papers/35644833 | PubMed |
| 5 | 28159534 | Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. | Lancet Infect Dis | 2017 | https://conductscience.org/library/papers/28159534 | PubMed |
| 6 | 23556021 | Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. | PLoS Negl Trop Dis | 2013 | https://conductscience.org/library/papers/23556021 | PubMed |
| 7 | 29423529 | Structure and function of Zika virus NS5 protein: perspectives for drug design. | Cell Mol Life Sci | 2018 | https://conductscience.org/library/papers/29423529 | PubMed |
| 8 | 34757841 | Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production. | J Virol | 2022 | https://conductscience.org/library/papers/34757841 | PubMed |
| 9 | 35766508 | MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro, In Vivo, and Ex Vivo. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/35766508 | PubMed |
| 10 | 32272626 | Flavivirus Nonstructural Protein NS5 Dysregulates HSP90 to Broadly Inhibit JAK/STAT Signaling. | Cells | 2020 | https://conductscience.org/library/papers/32272626 | PubMed |
| 11 | 14696330 | 5'- and 3'-noncoding regions in flavivirus RNA. | Adv Virus Res | 2003 | https://conductscience.org/library/papers/14696330 | PubMed |
| 12 | 38195857 | A conformational selection mechanism of flavivirus NS5 for species-specific STAT2 inhibition. | Commun Biol | 2024 | https://conductscience.org/library/papers/38195857 | PubMed |
| 13 | 33238464 | Drug Repurposing Approaches to Combating Viral Infections. | J Clin Med | 2020 | https://conductscience.org/library/papers/33238464 | PubMed |
| 14 | 25033077 | Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Reunion Island. | PLoS Negl Trop Dis | 2014 | https://conductscience.org/library/papers/25033077 | PubMed |
| 15 | 30107869 | Early start of the West Nile fever transmission season 2018 in Europe. | Euro Surveill | 2018 | https://conductscience.org/library/papers/30107869 | PubMed |
| 16 | 36364196 | Progression of Antiviral Agents Targeting Viral Polymerases. | Molecules | 2022 | https://conductscience.org/library/papers/36364196 | PubMed |
| 17 | 30455237 | Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30455237 | PubMed |
| 18 | 18069894 | A single mutation in chikungunya virus affects vector specificity and epidemic potential. | PLoS Pathog | 2007 | https://conductscience.org/library/papers/18069894 | PubMed |
| 19 | 33168456 | Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach. | J Infect Public Health | 2020 | https://conductscience.org/library/papers/33168456 | PubMed |
| 20 | 28129253 | HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa. | J Acquir Immune Defic Syndr | 2017 | https://conductscience.org/library/papers/28129253 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979326 | Clinical and immunological insights into chikungunya virus infection in people living with HIV. | Biosaf Health | 2026 | https://conductscience.org/library/papers/42979326 | PubMed |
| 42579068 | Prevalence and characterization of West Nile virus infections among people living with HIV in Northern Italy: a sero-repository analysis. | Infection | 2026 | https://conductscience.org/library/papers/42579068 | PubMed |
| 42553252 | Downregulation of thioredoxin-like 1 contributes to miconazole's antiviral activity against West Nile virus. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42553252 | PubMed |
| 42392364 | Retinoic acid is a translation inhibitor against chikungunya virus both in vitro and invivo. | Virol Sin | 2026 | https://conductscience.org/library/papers/42392364 | PubMed |
| 42368589 | Recent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368589 | PubMed |
| 41657861 | A brief review of chikungunya fever: From molecular virology to countermeasures. | Infect Med (Beijing) | 2026 | https://conductscience.org/library/papers/41657861 | PubMed |
| 41267781 | West Nile virus unmasked: from gene variability to future challenges. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41267781 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39339151
GET https://conductscience.org/api/papers/v1/39339151/references?page=2